Immune checkpoint inhibitor‐induced myasthenia gravis, myocarditis, and myositis: A case report

Key Clinical Message Immune checkpoint inhibitors can rarely lead to occurrence of myositis, myocarditis, and myasthenia gravis (MG). Early recognition and multidisciplinary management are crucial for optimal outcomes. Vigilance for overlapping toxicities is essential in patients receiving combinati...

Полное описание

Библиографические подробности

Главные авторы:	Arjun Basnet, Nava Raj Sharma, Sudarshan Gautam, Saral Lamichhane, Sajog Kansakar, Kripa Tiwari, Madalasa Pokhrel, Sehajpreet Singh
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Wiley 2024-06-01
Серии:	Clinical Case Reports
Предметы:	immune checkpoint inhibitors myasthenia myocarditis myositis
Online-ссылка:	https://doi.org/10.1002/ccr3.8968
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!